4-Bromobenzo[b]thiophene CAS 5118-13-8 Purity>97.0% (GC) Brexpiprazole Intermediate Manufacturer
Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-imodzi CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3
Dzina la Chemical | 4-Bromobenzo[b]thiophene |
Mawu ofanana ndi mawu | 4-Bromobenzothiophene;4-Bromo-Benzo[b]thiophene;4-Bromo-1-Benzothiophene |
Nambala ya CAS | 5118-13-8 |
Nambala ya CAT | Chithunzi cha RF-PI1103 |
Stock Status | Mu Stock, Mphamvu 30MT/Chaka |
Molecular Formula | C8H5BrS |
Kulemera kwa Maselo | 213.09 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Wolimba Wa Yellow |
Kuyera / Kusanthula Njira | >97.0% (GC) |
Infrared Spectrum | Zimagwirizana ndi Kapangidwe |
NMR | Zimagwirizana ndi Kapangidwe |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Pakati pa Brexpiprazole (CAS: 913611-97-9) |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
4-Bromobenzo[b]thiophene (CAS: 5118-13-8) imagwiritsidwa ntchito ngati chopangira chapakatikati, ndipo imatumizidwa makamaka ku India, North America, Korea, Japan, ndi Europe.4-Bromobenzo[b]thiophene ndi wapakatikati wa Brexpiprazole (CAS: 913611-97-9).Brexpiprazole inavomerezedwa ndi US Food and Drug Administration (FDA) pa July 10, 2015, pofuna kuchiza schizophrenia, komanso ngati chithandizo chothandizira kuvutika maganizo.Brexpiprazole idapangidwa kuti izipereka mphamvu komanso kulolera bwino (mwachitsanzo, akathisia pang'ono, kusakhazikika komanso / kapena kusowa tulo) pamankhwala omwe akhazikitsidwa azovuta zazikulu zakukhumudwa (MDD).Brexpiprazole, yogulitsidwa pansi pa dzina la Rexulti pakati pa ena, ndi antipsychotic atypical.Brexpiprazole ndi dopamine D2 receptor partial agonist ndipo amatchedwa "serotonin-dopamine activity modulator" (SDAM).Brexpiprazole idapangidwa ndi Otsuka ndi Lundbeck, ndipo imadziwika kuti ndiyolowa m'malo mwa Otsuka's atypical antipsychotic aripiprazole (Abilify) omwe amagulitsidwa kwambiri.